Proposed
Bill · 119th Congress · HR 3789
DTC Act of 2025
Refreshed 5 h ago
Introduced 2025-06-05Topic: health careSummary
Summary by the Congressional Research ServiceDrug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025 This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage. The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply. Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Sponsors
- David J. Taylor Republican sponsor
- 8 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2025-06-05 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2025-06-05 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2025-06-05 | Introduced in House | introduce | |
| 2025-06-05 | Introduced in House | introduce |